252 related articles for article (PubMed ID: 27181889)
1. [Roles of MicroRNA-21 in the Pathogenesis of Insulin Resistance and Diabetic Mellitus-induced Non-alcoholic Fatty Liver Disease].
Zhao XY; Shao K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Apr; 38(2):144-9. PubMed ID: 27181889
[TBL] [Abstract][Full Text] [Related]
2. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
Zheng F; Cai Y
Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent therapeutic roles of nitazoxanide on high-fat diet/streptozotocin-induced diabetes in rats: effects on hepatic peroxisome proliferator-activated receptor-gamma receptors.
Elaidy SM; Hussain MA; El-Kherbetawy MK
Can J Physiol Pharmacol; 2018 May; 96(5):485-497. PubMed ID: 29244961
[TBL] [Abstract][Full Text] [Related]
5. Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice.
Rhee KJ; Lee CG; Kim SW; Gim DH; Kim HC; Jung BD
Int J Med Sci; 2015; 12(12):987-94. PubMed ID: 26664261
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
[TBL] [Abstract][Full Text] [Related]
7. [Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis].
Shi T; Zhuang R; Zhou H; Wang F; Shao Y; Cai Z
Zhonghua Gan Zang Bing Za Zhi; 2015 Feb; 23(2):124-9. PubMed ID: 25880979
[TBL] [Abstract][Full Text] [Related]
8. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice.
de Mendonça M; de Sousa É; da Paixão AO; Araújo Dos Santos B; Roveratti Spagnol A; Murata GM; Araújo HN; Imamura de Lima T; Passos Simões Fróes Guimarães DS; Silveira LR; Rodrigues AC
Mol Cell Endocrinol; 2020 Feb; 501():110661. PubMed ID: 31770568
[TBL] [Abstract][Full Text] [Related]
10. The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway.
Ramadan NM; Elmasry K; Elsayed HRH; El-Mesery A; Eraky SM
Life Sci; 2022 Dec; 311(Pt A):121145. PubMed ID: 36336129
[TBL] [Abstract][Full Text] [Related]
11. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ.
Zhang M; Zhou Z; Wang J; Li S
Immunol Lett; 2016 Dec; 180():1-8. PubMed ID: 27746169
[TBL] [Abstract][Full Text] [Related]
12. MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-γ-mediated PI3K/AKT signaling.
Chen T; Zhang Y; Liu Y; Zhu D; Yu J; Li G; Sun Z; Wang W; Jiang H; Hong Z
Aging (Albany NY); 2019 Sep; 11(18):7510-7524. PubMed ID: 31562809
[TBL] [Abstract][Full Text] [Related]
13. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
[TBL] [Abstract][Full Text] [Related]
14. [Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ].
Wang L; Wang GL; Liu JH; Li D; Zhu DZ; Wu LN
Zhong Xi Yi Jie He Xue Bao; 2012 Jul; 10(7):793-9. PubMed ID: 22805086
[TBL] [Abstract][Full Text] [Related]
15. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Sitagliptin on Lipid Metabolism of Fatty Liver Mice and Related Mechanisms.
Xu B; Shen T; Chen L; Xia J; Zhang C; Wang H; Yu M; Lei T
Med Sci Monit; 2017 Mar; 23():1363-1370. PubMed ID: 28315901
[TBL] [Abstract][Full Text] [Related]
17. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
18. The effect of aerobic, resistance, and combined training on PPAR-α, SIRT1 gene expression, and insulin resistance in high-fat diet-induced NAFLD male rats.
Nikroo H; Hosseini SRA; Fathi M; Sardar MA; Khazaei M
Physiol Behav; 2020 Dec; 227():113149. PubMed ID: 32888948
[TBL] [Abstract][Full Text] [Related]
19. [Effect of targeted inhibition of hypoxia-inducible factor-1α by 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole on the progression of non-alcoholic fatty liver disease in rats].
Shen WD; Zhang W; Xu QH; Liu PF
Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):749-754. PubMed ID: 27938560
[No Abstract] [Full Text] [Related]
20. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
